The aacCI gene encoding the 3-N-aminoglycoside acetyltransferase [AAC (3) 
DNA probes are useful tools for studying the epidemiology of both infectious microorganisms and antimicrobial resistance genes (52, 53) . Probes directed against the sequences of the structural genes of a variety of antimicrobial resistance determinants have been used to study the dissemination of these genetic elements in hospitals and ecological communities (13, 52, 55) . Since the presence of flanking sequences in probes to resistance genes can lead to falsepositive results, it is preferable to select a probe from within the open reading frame (ORF) of the gene to be identified (33, 51) .
Recently, Cameron et al. reported the DNA sequence of the 2"-O-aminoglycoside adenylyltransferase [AAD(2")] resistance gene (12) and noted that the flanking sequences of other aminoglycoside and trimethoprim resistance genes were similar to the corresponding regions upstream and downstream of the AAD(2") gene. Ouellette et al. made similar observations while investigating hot spots of recombination in transposon Tn2J (41) . Such regions of homology are apparently common in transposons, such as Tn2J, Tn2411, and others (31, 45) . The presence of such widespread homology among resistance genes suggests that probes developed for such genes must be carefully chosen so as to avoid shared sequences. We are interested in studying the epidemiology of the aminoglycoside acetylases, a diverse group of enzymes with a broad distribution in nature (5, 9, 16, 37, 39, 46) . Approximately 5% of gentamicin-resistant gram-negative organisms in the United States contain the 3-N-aminoglycoside acetyltransferase [AAC(3)-I] gene (37) . This gene has been noted in a hospital outbreak of gentamicin-resistant enteric bacilli in England (11) . Although the amino-terminal end of the AAC(3)-I protein has been sequenced (26) , the nucleotide sequence of the aacCl gene has not been reported. Herein we present the development of a DNA probe for the aacCl gene from its nucleotide sequence and the testing of its utility for screening a group of clinical isolates from the Seattle Veterans Administration Medical Center.
MATERIALS AND METHODS
Bacterial strains and plasmids. Escherichia coli PS4221 (Schering Corp., Bloomfield, N.J.; no. 72091801) harboring plasmid pJR88, also known as R135 and RIP135 (10, 30, 60) , was obtained from R. Hare of the Schering Corp. Frozen competent cells of E. coli DH5ot were obtained from Bethesda Research Laboratories, Inc., Gaithersburg, Md. E. coli C600 was obtained from L. Tompkins (Stanford University, Stanford, Calif.). Both were used as recipient strains for transformation of plasmids. The cloning vectors employed, pBR322, pUC18, and pUC19, have been described previously (3) . E. coli JM103 was the recipient strain for M13 bacteriophage vectors M13mpl8 and M13mpl9. The remaining study isolates are listed below (see Tables 1 to 4 Beverly, Mass., or Bethesda Research Laboratories and were used according to the specifications of the manufacturers. Gentamicin was provided by Schering; ampicillin and tetracycline were purchased from Sigma Chemical Co., St. Louis, Mo. Plasmid DNA was transformed into E. coli C600 by the method of Cohen et al. (15) . Transformed E. coli isolates were selected for the presence of recombinant plasmids on brain heart infusion agar (Difco Laboratories, Detroit, Mich.) or L agar containing 5 ,ug of gentamicin per ml and either 50 ,ug of ampicillin or 15 pLg of tetracycline per ml. The presence or absence of the AAC(3)-I phenotype (gentamicin resistance; amikacin, kanamycin, and tobramycin susceptibility) was d,etermined by disk diffusion (4) or microdilution MIC profiles (37) . Susceptibility to sulfonamides was determined by disk diffusion with a 250-,ug disk, and resistance to mercury (defined as growth in the presence of 20 ,ug of HgCl2 per ml) was determined by an agar dilution method, using brain heart infusion agar. (38) . In addition, the standard sequencing gel composition (35) was modified by the addition of various concentrations of formamide (6) . Computer analysis. The DNA sequence of the aacCl gene and the predicted gene product sequence were analyzed by using Intelligenetics software (Mountainview, Calif.) and homology search programs by Lipman and Pearson (32) . The sequences were compared with the GenBank (7) and EMBL (24) nucleotide sequence data banks and the PIR (protein identification resource) protein data bank (20, 34, 40) .
Probe preparation. Recombinant plasmid pFCT4392 was digested with AvaI, and the fragments were separated on a 1.5% agarose gel. The 845-base-pair (bp) band was excised from the gel, electroeluted into 0.1 M Tris borate buffer (pH 7.5), and purified by passage through an Elutip-d column (Schleicher & Schuell, Inc., Keene, N.H.). The DNA was then digested with EcoRV, and the fragments were electrophoresed through a 2.0% agarose gel. The 307-bp band was excised, purified as described above, and nick translated with 32p, using a commercial labeling system (Bethesda Research Laboratories).
DNA hybridization studies. Duplicate nitrocellulose filters (Schleicher & Schuell) were spotted with 10 ,ul of organisms grown overnight in Trypticase soy broth (BBL Microbiology Systems, Cockeysville, Md.) (ca. 109 CFU/ml). Organisms were lysed as previously described (21) (26) . The bottom row of letters represents amino acids predicted by DNA sequence (X, unknown amino acid). The end of homology with other resistance determinants (*) is indicated. The aacCl DNA probe is the fragment bounded by the AvaI and EcoRV sites.
film (X-Omat AR; Eastman Kodak Co., Rochester, N.Y.) with intensifying screens at -70°C for 24 to 48 h.
RESULTS
Cloning and nucleotide sequence determination of the AAC(3)-I gene. To facilitate the development of a specific DNA probe, the aacCl gene was cloned from the enteric plasmid pJR88 by inserting an 8.5-kilobase EcoRI fragment from pJR88 into the EcoRI site of pBR322. The resulting 12.8-kilobase plasmid was named pFCT3111 (Fig. 1) . The restriction endonuclease map of the insert is similar to that of Tn2J, described by Kratz et al. (31) . Indeed, this plasmid confers both sulfonamide and streptomycin resistance to its host strain, as is common for Tn21-like elements (31, 45) . A mercury resistance determinant does not appear to be present on pFCT3111, but pJR88 does contain a mercury resistance gene, adding support to the presence of a Tn21-like element on pJR88. Two consecutive deletions of pFCT3111 generated by PvuI and HincIl digestion produced plasmid pFCT4374 (Fig. 1) , which conferred the gentamicin resistance (Gmr) phenotype to recipient E. coli cells after transformation. A 780-bp HincII-EagI fragment from pFCT4374 was subcloned into the 3.6-kilobase EagI-EcoRV fragment of pBR322, producing a 4.4-kilobase plasmid, designated pFCT4392 (Fig. 1) , that produced the Gmr phenotype when transformed into E. coli recipients.
The nucleotide sequence of 1,082 bp of the HincII-PvuI fragment from pFCT4374 which includes the aacCl gene and flanking sequences was determined (Fig. 2) codon (Fig. 2) . Only two differences were noted between the amino acid sequence predicted from the DNA sequence and that which was previously determined by biochemical methods. First, the DNA sequence predicts a serine residue in place of an alanine at nucleotides 255 to 257. Second, an arginine residue is predicted at nucleotides 258 to 260 which was previously reported as an unidentifiable amino acid ( This novel plasmid, pFCT4400, no longer confers the Gmr phenotype to E. coli transformants containing the altered plasmid.
OXA-2 (R46)
A search of the PIR (release 14.0) data bank failed to reveal any significant matches with other protein sequences. Specific searches of the protein sequences encoded by drug resistance genes dhfrll (dihydrofolate reductase type II) from R388 (62), aadA from R538-1 (25), OXA-2 from R46 (23), dhfrll from R751 (18), aadB from pDGO100 (12) , aacA4 from pAZO07 (57), aacC4 from pWP7b (8), aacC3 from three plasmids (1), aadA from pCN1 (14) , OXA-1 from RGN238 (41), and aacAl from pFCT1163 (54) were unrevealing.
Expression of plasmid-encoded proteins in maxicells. To confirm that the protein produced by the ORF of the cloned aacCl gene was similar to that produced in vivo and to confirm the direction of transcription of the aacCl gene, the proteins encoded by plasmids pFCT3111, pFCT4374, pFCT4392, and pFCT4400 were examined in E. coli maxicells. Autoradiographs of 15 to 18% sodium dodecyl sulfatepolyacrylamide gels showed a similar 19-kilodalton protein in maxicell preparations from the three Gmr clones pFCT3111, pFCT4374, and pFCT4392 (data not shown). This 19-kilodalton protein was the only non-pBR322-derived protein in these preparations and correlates well with the 19,388-dalton polypeptide predicted by using the first ATG codon in the 549-nucleotide ORF. Preparations from gentamicin-susceptible maxicells containing pFCT4400 demonstrated a protein similar in size to that produced by the three Gmr strains.
Nucleotide sequence homologies. A comparison of the first 277 bp of the aacCI sequence from the HincII site at 0 through the first 59 bp of the ORF (bp 277) with the 5'-flanking regions of a number of plasmid-borne genes that mediate antimicrobial resistance revealed extensive sequence homologies (Fig. 3) . These genes include the aacAl 6'-N-aminoglycoside acetyltransferase [AAC(6')-I] gene on pFCT1163, the aadB gene on plasmid pDGO100, the OXA-1 gene on RGN238, the dhfrII gene on pMT100 (49), the dhfrll gene from R388, the dhfrlI gene from R751, the aadA gene from R538-1, the OXA-2 gene on R46, the dhfrV gene on pLMO20 (48) , and a portion of the PSE-2 gene from pMON234 (27) . A comparison of the sequence data suggests that the aadB gene and the dihydrofolate reductase genes from pMT100, R388, and R751, as well as the OXA-2 gene and dhfrV gene, share the -35 and -10 sites with aacCl, while the AAC(6')-I gene, the OXA-1 gene on RGN238, and the aadA from R538-1 utilize the -35 and -10 sequences downstream at nucleotides 124 to 130 and 148 to 153 (Fig. 3) , where the insertion of the nucleotides GGG creates the (Fig. 3) . Neither leader sequences nor signal peptides appear to be encoded by these shared regions.
GYCTAACAATTCGTTCAAGCCGACGCCGCTTCGCGGC-GCGG ---------------------------------CTTAACTCARCCGTTAGA

Tn7: GTCTAACAATTCGTTCAAGCCGACGCCGCTTCGCGGC-GCGG-----------------------------------------------
In addition to the sequence similarity observed in the 5'-flanking region of the ORF, similarities in the region 3' to the aacCl gene were also noted with the above genes. Cameron et al. (12) proposed a consensus sequence of the 3'-flanking sequences that was 54 to 59 bp in length. This consensus sequence and the Tn7 repeat of Fling et al. (19) are compared with the corresponding region of aacCl in Fig.  4 . Again, the aacCl sequence displays an insertion relative to the other sequences. This insertion, 48 bp in length, encompasses nucleotides 789 to 836 (Fig. 2) . Even with this insert, the 3' flank of the aacCl gene is still capable of forming a hairpin structure, as are the other sequences. However, in this case, the hairpin encompasses 107 nucleotides rather than 54 or 59 ( Fig. 3) (Fig. 2 ). This fragment was purified, labeled, and hybridized to DNA obtained from a series of genetically defined control strains harboring a variety of aminoglycoside resistance genes ( Table 1 ). The probe hybridized only with the DNA of the strain demonstrating AAC(3)-I activity (PS886). Second, the DNAs from a series of reference strains demonstrating 3'-acetylating activity by phosphocellulose paper-binding assay (22) or MIC profile (37) were examined with the probe (Table 2) . Homology was noted with four strains of Pseudomonas aeruginosa. One was previously classified as an AAC(3)-I-producing strain, another as an unclassified AAC(3) producer, the third as an AAC(3)-III producer, and the last as an AAC(3)-Ia producer. The remaining isolates in this group tested negative with the probe. A third group of 25 isolates obtained from the Seattle Veterans Administration Medical Center, which had been characterized by the MIC profile method, was examined (Table 3) . Only two strains, Fig. 1 , panel C of reference 31), although our fragment shows two insertions in this area. The first insertion is the aacCl gene, and the second does not produce a detectable phenotype. The presence of sulfonamide and streptomycin resistance genes on the cloned fragment in pFCT3111, in addition to the presence of a mercury resistance gene on pJR88, supports the presence of a Tn2J-like element on pJR88. However, the ability of the aacCl gene to transpose from pJR88 to another replicon has not been investigated.
With regard to probe development, our initial attempts to prepare a restriction fragment probe for the aacCl gene before determining the nucleotide sequence were unsuccessful. Each restriction fragment probe we tested demonstrated homology with plasmid DNA encoding aminoglycoside resistance genes other than aacCl. The DNA sequencing data from the aacCl gene revealed that those probes extended beyond the boundaries of the AAC(3)-I ORF or included the first 59 bp of the ORF of aacCL. This reinforces the benefits of developing probes from known nucleotide sequences.
To test the specificity of the aacCl probe, it was necessary to assemble a series of genetically defined strains containing known aminoglycoside resistance genes. From our studies with these organisms, and particularly with the so-called enzymatically defined isolates, it was clear that probes are superior to the MIC-typing method and phosphocellulose paper-binding assay for classifying aminoglycoside resistance genes in bacterial isolates. While the MIC method of Miller et al. (37) is more reliable in our estimation than the phosphocellulose paper-binding assay, it is limited by its inability to detect and classify phosphotransferases and the inability to detect certain combinations of enzymes, such as AAC(2') in the presence of an aadB gene (46) . The development of additional probes for aminoglycoside, ,B-lactamase, and trimethoprim resistance genes must be undertaken cautiously so as not to include the flanking sequences that are so commonly present, particularly among genes involved in the Tn2J family of elements. It was for this reason that we chose to determine the DNA sequence of the aacCl gene.
Several studies using traditional methods have attempted to delineate the presence of various resistance genes in clinical isolates of bacteria (16, 29, 37, 46) . These studies, while important, have been hampered by the limitations of the techniques employed. More recent studies using batteries of DNA probes to various resistance genes demonstrate the value of hybridization assays for screening large numbers of organisms quickly and efficiently, limited only by the numbers of probes employed (2, 28, 47, 52) . Additional probe studies will help us to understand the epidemiology of resistance genes, how genes disseminate in nature, and the role of transposons, such as Tn2J, in this process.
